NCT05737030View on ClinicalTrials.gov

Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

July 23, 2024

Study Completion Date

December 31, 2025

Conditions
Cirrhosis
Interventions
DRUG

L-ornithine L-aspartate

Amino acid combination

Trial Locations (1)

8010

Department of Internal Medicine, Medical University of Graz, Graz

All Listed Sponsors
collaborator

CBmed Ges.m.b.H.

OTHER

lead

Medical University of Graz

OTHER